Garrison Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$211K Hold
1,860
0.11% 106
2024
Q2
$230K Sell
1,860
-106
-5% -$13.7K 0.12% 99
2024
Q1
$259K Sell
1,966
-29
-1% -$3.57K 0.14% 97
2023
Q4
$217K Buy
1,995
+1
+0.1% +$104 0.12% 104
2023
Q3
$205K Buy
1,994
+1
+0.1% +$108 0.13% 99
2023
Q2
$230K Sell
1,993
-343
-15% -$38.9K 0.14% 92
2023
Q1
$249K Sell
2,336
-9
-0.4% -$972 0.15% 93
2022
Q4
$260K Buy
2,345
+1
+0% +$102 0.17% 86
2022
Q3
$202K Buy
+2,344
New +$209K 0.14% 92

Other funds holding MRK

Garrison Asset Management's MRK Position: Q3 2024 in Review

Garrison Asset Management held its Merck (MRK) position steady in Q3 2024 at 1,860 shares worth $211K. The position accounts for 0.11% of the portfolio, ranked #106.

Garrison Asset Management first reported a position in MRK in Q3 2022 and has held it in 9 quarters since. The position peaked at $260K in Q4 2022. 3,490 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

  • Garrison Asset Management held 1,860 shares of Merck worth $211K as of Q3 2024.
  • Garrison Asset Management left its Merck share count unchanged in Q3 2024.
  • Merck made up 0.11% of Garrison Asset Management's portfolio in Q3 2024, its #106 holding.
  • Garrison Asset Management first reported a position in Merck in Q3 2022 and has held it in 9 quarters since.
  • Garrison Asset Management's Merck position peaked at $260K in Q4 2022.
  • 3,490 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Garrison Asset Management's 13F filing for Q3 2024, filed 30 Oct 2024.